This paper presents a sequential learning framework for sensors in a network, where a few sensors assume the role of an instructor to train other sensors in the network. The instructors provide estimated labels for measurements of new sensors. These labels are possibly noisy, because a classifier of the instructor may not be perfect. A recursive density estimator is proposed to obtain the true measurement model (i.e., the observation density conditioned on the label) in spite of the training with noisy labels. Specifically, this paper answers the question "Can a sensor train other sensors?", provides necessary conditions for sensors to act as instructors, presents a sequential learning framework using recursive nonparametric kernel density estimation, and provides a convergence rate for the expected error in an observation density. The underlying concepts are illustrated and validated with simulation results.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TNNLS.2018.2791898DOI Listing

Publication Analysis

Top Keywords

presents sequential
8
sequential learning
8
learning framework
8
sensors network
8
observation density
8
sensors
5
learning multiple
4
multiple imperfect
4
imperfect instructors
4
instructors sensor
4

Similar Publications

Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide.

JAMA Ophthalmol

January 2025

John A. Moran Eye Center, Department of Ophthalmology & Visual Sciences, Department of Neurology, University of Utah Health, Salt Lake City.

Importance: Nearly 2% of the US population received a prescription for semaglutide in 2023. There has been a recent concern that this drug and other similar medications may be associated with ophthalmic complications.

Objective: To report ophthalmic complications associated with the use of semaglutide or tirzepatide.

View Article and Find Full Text PDF

Turmeric is affected by various phytopathogens, which cause huge economic losses to farmers. In the present study, ten isolates of Pythium spp. were isolated from infected turmeric rhizomes and characterized.

View Article and Find Full Text PDF

[An update on surgical treatment options for inflammatory bowel disease].

Inn Med (Heidelb)

January 2025

Klinik für Allgemein‑, Viszeral- und Thoraxchirurgie, Klinikum Darmstadt GmbH, Grafenstraße 9, 64283, Darmstadt, Deutschland.

There are national and international guidelines and developments for the surgery of chronic inflammatory bowel disease (IBD) that contribute to better patient care. Important recommendations include increasingly individualized and minimally invasive approaches with the integration of new technologies. The indication for abdominal surgery remains tied to specialization, not least in order to continue to be able to assess the importance of sequential treatment and multimodality in improving surgical results and minimizing risks.

View Article and Find Full Text PDF

Background: Radio-chemotherapy remains the mainstay of glioblastoma first-line treatment after extended surgery, but the prognosis is still poor. PARP inhibitors like olaparib may improve glioblastoma outcomes. We implemented a phase 1-2a trial to assess the safety and efficacy of olaparib combined with standard radio-chemotherapy as a first-line treatment in unresected glioblastoma patients.

View Article and Find Full Text PDF

Insufficient radio-frequency ablation (IRFA) of hepatocellular carcinoma accelerates the recurrence of residual tumor, leading to a poor prognosis. Neutrophils (NEs), as the initial leukocytes to infiltrate the IRFA-associated inflammatory area, were utilized as drug carriers due to their inherent chemotactic properties for targeted delivery of chemotherapy drugs to the inflammatory site where residual tumor persists post-IRFA. Previous research has highlighted that the immunosuppressive cytokines in the tumor microenvironment could promote the transition of NEs into a protumorigenic phenotype.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!